The Antioxidant and Skin-Brightening Effects of a Novel Caffeic Acid Derivative, Caffeic Acid-3,4-Dihydroxyphenylpropanolester
Antioxidants · 29.06.2025 · 14 (7) · 806
DOI: 10.3390/antiox14070806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 29.06.2025. Verfasst von Kyu-Lim Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Health and Welfare, Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI).
Abstract (Originalsprache)
Caffeic acid (CA) is a naturally occurring polyphenol antioxidant found in coffee, tea, fruits, and vegetables, known for its strong antioxidant, anti-inflammatory, and anti-aging properties. However, its cosmetic application is limited because of poor dermal absorption due to its high polarity. This study aimed to evaluate the antioxidant and skin-brightening effects of a novel lipophilic CA derivative, CAD (caffeic acid-3,4-dihydroxyphenylpropanolester). CAD was synthesized by conjugating CA with 3,4-DHPEA, a lipophilic antioxidant derived from olive oil. In both DPPH and ABTS assays, CAD exhibited more potent antioxidant activity than CA. In B16F10 melanoma cells, CAD significantly inhibited melanin production without cytotoxicity at concentrations lower than those required for CA. Cellular assays using DCF-DA staining demonstrated that CAD effectively reduced intracellular ROS levels. Mechanistic studies revealed that CAD inhibited tyrosinase activity and downregulated the expression of TYR, TRP-1, and TRP-2. Additionally, CAD suppressed MITF phosphorylation, along with reduced phosphorylation of ERK and JNK, elucidating its anti-melanogenic mechanism. Importantly, CAD showed dose-dependent skin-brightening effects in the 3D human skin model Melanoderm™, as evidenced by increased lightness and histological evaluation. In conclusion, CAD demonstrates strong potential as a safe and effective antioxidant and skin-brightening agent for cosmetic applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
- Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul 03760, Republic of Korea.
- ACTIVON Co., Ltd., Cheongju 28104, Republic of Korea.
- Qmine Co., Ltd., Suwon 16506, Republic of Korea.
ORCID-Profile: Kyung-Min Lim
Förderung
- National Research Foundation of Korea
- Ministry of Health and Welfare
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
- Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Kim, K. L., Jeon, J. H., Kim, Y., & Lim, K. M. (2025). The Antioxidant and Skin-Brightening Effects of a Novel Caffeic Acid Derivative, Caffeic Acid-3,4-Dihydroxyphenylpropanolester. Antioxidants, 14(7), 806. https://doi.org/10.3390/antiox14070806
Vancouver
Kim KL, Jeon JH, Kim Y, Lim KM. The Antioxidant and Skin-Brightening Effects of a Novel Caffeic Acid Derivative, Caffeic Acid-3,4-Dihydroxyphenylpropanolester. Antioxidants. 2025;14(7):806. doi:10.3390/antiox14070806
BibTeX
@article{Kim2025,
author = {Kim, Kyu-Lim and Jeon, Ju-Hee and Kim, Yeonjoon and Lim, Kyung-Min},
title = {The Antioxidant and Skin-Brightening Effects of a Novel Caffeic Acid Derivative, Caffeic Acid-3,4-Dihydroxyphenylpropanolester},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {7},
pages = {806},
doi = {10.3390/antiox14070806}
}
EUVIMED